Cirqle Biomedical Contraception ApS: Financial statements 2023
CVR: 39865769
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Cirqle Biomedical Contraception ApS (CVR 39865769) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -12,848,480 and a net result of DKK -15,984,818 compared with DKK 47,682,044 the year before. Equity in the 2023 report amounted to DKK 34,366,383. The solvency ratio was 74.8%. The company had 9 employees in the financial year.
- Gross Profit
- DKK -12,848,480
- Profit/Loss
- DKK -15,984,818
- Equity
- DKK 34,366,383
- Total Assets
- DKK 45,935,733
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -12.8 mio. | -16 mio. | 34.4 mio. | 9 |
| 2022 | - | 62.1 mio. | 47.7 mio. | 50.4 mio. | 5 |
| 2021 | - | -5.8 mio. | -7.2 mio. | -4.4 mio. | 5 |
| 2020 | - | -4.1 mio. | -5.6 mio. | 2.8 mio. | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Cirqle Biomedical Contraception ApS has published its annual report for 2022. Gross profit came to DKK 62,142,237, and the net result was DKK 47,682,044.
About Cirqle Biomedical Contraception ApS
Cirqle Biomedical Contraception ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cirqle Biomedical Contraception IVS and Circle Biomedical Contraception IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The board consists of Jesper Boysen (chair), Frederik Petursson Madsen and Thomas Crouzier. The company is owned by Cirqle Biomedical Holding ApS and RH CAPITAL FUND II, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -2,426,548 and a net result of DKK -6,409,656 compared with DKK 43,425,442 the year before. Equity in the 2025 report amounted to DKK 29,520,931.